- Adityanjee

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi Neuropsychiatric sequelae of neuroleptic malignant syndrome
    - Adityanjee
    Schizophrenia and Psychotic Disorders Program, VA Medical Center, Minneapolis, Minnesota 55417, USA
    Clin Neuropharmacol 28:197-204. 2005
  2. ncbi The syndrome of irreversible lithium-effectuated neurotoxicity
    - Adityanjee
    Schizophrenia and Psychotic Disorders Program, Psychiatry Service, Minneapolis VA Medical Center, Minneapolis, Minnesota 55417, USA
    Clin Neuropharmacol 28:38-49. 2005
  3. ncbi Clinical use of quetiapine in disease states other than schizophrenia
    - Adityanjee
    Department of Psychiatry, University of Minnesota Medical School, Minneapolis, Minn 55454 1495, USA
    J Clin Psychiatry 63:32-8. 2002
  4. ncbi A comparative pilot study of second-generation antipsychotics in children and adolescents with schizophrenia-spectrum disorders
    Jonathan B Jensen
    University of Minnesota, Department of Psychiatry, Minneapolis, Minnesota 55454, USA
    J Child Adolesc Psychopharmacol 18:317-26. 2008
  5. ncbi Structural and diffusion tensor imaging of the fornix in childhood- and adolescent-onset schizophrenia
    Mustafa Kendi
    University of Minnesota, Minneapolis, MN 55454, USA
    J Am Acad Child Adolesc Psychiatry 47:826-32. 2008
  6. ncbi Disruption of hippocampal connectivity in children and adolescents with schizophrenia--a voxel-based diffusion tensor imaging study
    Tonya White
    Department of Psychiatry, University of Minnesota, Minneapolis, MN 55454, USA
    Schizophr Res 90:302-7. 2007
  7. ncbi Frontal white matter integrity in borderline personality disorder with self-injurious behavior
    Jon E Grant
    Department of Psychiatry, University of Minnesota Medical Center, University of Minnesota, Minneapolis, MN, USA
    J Neuropsychiatry Clin Neurosci 19:383-90. 2007
  8. ncbi Clinical and neurocognitive course in early-onset psychosis: a longitudinal study of adolescents with schizophrenia-spectrum disorders
    Jeffrey R Wozniak
    Department of Psychiatry, University of Minnesota Medical Center Twin Cities, Minneapolis, Minnesota 55454, USA
    Early Interv Psychiatry 2:169-77. 2008
  9. ncbi Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study
    S Charles Schulz
    Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN 55454, USA
    Br J Psychiatry 193:485-92. 2008
  10. ncbi What we know: findings that every theory of schizophrenia should explain
    Angus W MacDonald
    Department of Psychology, University of Minnesota, N426 Elliott Hall, 75 E River Rd, Minneapolis, MN 55455, USA
    Schizophr Bull 35:493-508. 2009

Detail Information

Publications25

  1. ncbi Neuropsychiatric sequelae of neuroleptic malignant syndrome
    - Adityanjee
    Schizophrenia and Psychotic Disorders Program, VA Medical Center, Minneapolis, Minnesota 55417, USA
    Clin Neuropharmacol 28:197-204. 2005
    ..Awareness of such outcomes and the use of evidence-based strategies to minimize risk factors will help clinicians in reducing the persistent sequelae of NMS...
  2. ncbi The syndrome of irreversible lithium-effectuated neurotoxicity
    - Adityanjee
    Schizophrenia and Psychotic Disorders Program, Psychiatry Service, Minneapolis VA Medical Center, Minneapolis, Minnesota 55417, USA
    Clin Neuropharmacol 28:38-49. 2005
    ..The authors review the published cases of SILENT reported in the literature and discuss various clinical manifestations...
  3. ncbi Clinical use of quetiapine in disease states other than schizophrenia
    - Adityanjee
    Department of Psychiatry, University of Minnesota Medical School, Minneapolis, Minn 55454 1495, USA
    J Clin Psychiatry 63:32-8. 2002
    ..These factors suggest that the clinical utility of quetiapine in psychiatric conditions other than schizophrenia has not been fully exploited thus far...
  4. ncbi A comparative pilot study of second-generation antipsychotics in children and adolescents with schizophrenia-spectrum disorders
    Jonathan B Jensen
    University of Minnesota, Department of Psychiatry, Minneapolis, Minnesota 55454, USA
    J Child Adolesc Psychopharmacol 18:317-26. 2008
    ..To plan the design of a subsequent randomized controlled trial (RCT), the authors conducted this pilot study to demonstrate the feasibility of the treatment and measurement protocols...
  5. ncbi Structural and diffusion tensor imaging of the fornix in childhood- and adolescent-onset schizophrenia
    Mustafa Kendi
    University of Minnesota, Minneapolis, MN 55454, USA
    J Am Acad Child Adolesc Psychiatry 47:826-32. 2008
    ..The fornix is the primary efferent neural pathway of the hippocampus and has been shown to be abnormal in adults with schizophrenia...
  6. ncbi Disruption of hippocampal connectivity in children and adolescents with schizophrenia--a voxel-based diffusion tensor imaging study
    Tonya White
    Department of Psychiatry, University of Minnesota, Minneapolis, MN 55454, USA
    Schizophr Res 90:302-7. 2007
    ..As white matter provides rapid and efficient communication between brain regions, this study was initiated to assess the early disruption of white matter pathways in children and adolescent with schizophrenia...
  7. ncbi Frontal white matter integrity in borderline personality disorder with self-injurious behavior
    Jon E Grant
    Department of Psychiatry, University of Minnesota Medical Center, University of Minnesota, Minneapolis, MN, USA
    J Neuropsychiatry Clin Neurosci 19:383-90. 2007
    ..Women with borderline personality disorder-self-injurious behavior exhibit decreased white matter microstructural integrity in inferior frontal brain regions that may include components of orbito-frontal circuitry...
  8. ncbi Clinical and neurocognitive course in early-onset psychosis: a longitudinal study of adolescents with schizophrenia-spectrum disorders
    Jeffrey R Wozniak
    Department of Psychiatry, University of Minnesota Medical Center Twin Cities, Minneapolis, Minnesota 55454, USA
    Early Interv Psychiatry 2:169-77. 2008
    ..The goals of this study were to examine these relationships in a larger sample at baseline, and also to examine the longitudinal course of these deficits in a smaller subset of adolescents...
  9. ncbi Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study
    S Charles Schulz
    Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN 55454, USA
    Br J Psychiatry 193:485-92. 2008
    ..Despite the prevalence and clinical significance of borderline personality disorder, its treatment remains understudied...
  10. ncbi What we know: findings that every theory of schizophrenia should explain
    Angus W MacDonald
    Department of Psychology, University of Minnesota, N426 Elliott Hall, 75 E River Rd, Minneapolis, MN 55455, USA
    Schizophr Bull 35:493-508. 2009
    ....
  11. ncbi Classification of adolescent psychotic disorders using linear discriminant analysis
    Patricia J Pardo
    The Domenici Research Center for Mental Illness, Brain Sciences Center, Minneapolis Veterans Affairs Medical Center, Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, 55454, USA
    Schizophr Res 87:297-306. 2006
    ..The differential diagnosis between schizophrenia and bipolar disorder during adolescence presents a major clinical problem. Can these two diagnoses be differentiated objectively early in the courses of illness?..
  12. ncbi The schizophrenia prodrome
    Tonya White
    Department of Psychiatry, University of Minnesota School of Medicine, Minneapolis, MN 55454, USA
    Am J Psychiatry 163:376-80. 2006
  13. ncbi Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia
    Melissa Terpstra
    Center for Magnetic Resonance Research, Department of Radiology, University of MN, Minneapolis, MN 55455, USA
    MAGMA 18:276-82. 2005
    ..A secondary objective was to compare several of the neurochemical concentrations quantified along with GSH using LCModel analysis of short echo time spectra in schizophrenia versus control...
  14. ncbi The efficacy of quetiapine vs haloperidol and placebo: a meta-analytic study of efficacy
    S Charles Schulz
    Department of Psychiatry, University of Minnesota Medical School, F282 2A West 2450 Riverside Avenue, Minneapolis, MN 55454, USA
    Schizophr Res 62:1-12. 2003
    ..The atypical antipsychotics that are currently commercially available are clozapine, risperidone, olanzapine, quetiapine, and ziprasidone. The focus of this report is on the efficacy of quetiapine...
  15. ncbi Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors
    David E Adson
    Department of Psychiatry, University of Minnesota, Minneapolis, Minnesota 55454 1495, USA
    Depress Anxiety 19:121-6. 2004
    ..Given the open-label design of the trial, more rigorous studies are clearly indicated...
  16. ncbi Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia
    S Hossein Fatemi
    Division of Neuroscience Research, Department of Psychiatry, University of Minnesota Medical School, MMC 392, Delaware Street 420, Minneapolis, MN 55455, USA
    Schizophr Res 69:317-23. 2004
    ....
  17. ncbi Trajectories of social withdrawal and cognitive decline in the schizophrenia prodrome
    Kathryn Cullen
    Department of Psychiatry, University of Minnesota School of Medicine, Minneapolis, MN, USA
    Clin Schizophr Relat Psychoses 4:229-38. 2011
    ..This study aimed to characterize developmental trajectories of premorbid social withdrawal and cognitive decline between patients with high versus low levels of negative symptoms in youth with schizophrenia-spectrum disorders...
  18. ncbi Quetiapine in patients with borderline personality disorder: an open-label trial
    - Adityanjee
    Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN 55454, USA
    Ann Clin Psychiatry 20:219-26. 2008
    ..Quetiapine was assessed in patients diagnosed with borderline personality disorder (BPD) to examine its potential effect on symptoms and explore a tolerated dosing pattern...
  19. ncbi A prospective, open-label trial of olanzapine in adolescents with schizophrenia
    Robert L Findling
    Department of Psychiatry, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, OH 44106, USA
    J Am Acad Child Adolesc Psychiatry 42:170-5. 2003
    ..Olanzapine is an atypical antipsychotic that has efficacy in adults with psychotic disorders. This preliminary study examined the effectiveness of olanzapine in adolescents with schizophrenia or its related conditions...
  20. ncbi Decreased memory loss associated with right unilateral ultra-brief pulse wave ECT
    Suck Won Kim
    Department of Psychiatry, University of Minnesota, USA
    Minn Med 90:34-5. 2007
    ..Patients treated with the method, ultra-brief pulse wave ECT, have less memory loss and confusion than those treated with longer-duration ECT...
  21. ncbi Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder
    Lusha Liu
    Department of Psychiatry, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA
    Cell Mol Neurobiol 27:351-8. 2007
    ..controls.5. These results indicate for the first time that pyramidal cell atrophy is present in hippocampus of subjects with bipolar disorder...
  22. ncbi Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices
    S Hossein Fatemi
    Department of Psychiatry, Division of Neuroscience Research, University of Minnesota Medical School, 420 Delaware Street SE, Mayo Building, Box 392, Minneapolis, MN 55455, USA
    Biol Psychiatry 52:805-10. 2002
    ..Glutamic acid decarboxylase deficiency may be due to or associated with abnormalities in levels of glutamate/gamma amino butyric acid, or transporter/receptor density in autistic brain...
  23. ncbi Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study
    Rene S Kahn
    Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center, Utrecht, The Netherlands
    J Clin Psychiatry 68:832-42. 2007
    ..To evaluate the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) in a 6-week, double-blind, randomized study...
  24. ncbi Increased presence of white matter hyperintensities in adolescent patients with bipolar disorder
    Jay J Pillai
    Department of Radiology, Division of Neuroradiology, The Medical College of Georgia, 1120 15th Street, Augusta, GA 30912, USA
    Psychiatry Res 114:51-6. 2002
    ..The association between WMH and bipolar disorder appears to extend to the adolescent years...
  25. ncbi Head size and schizophrenia
    Peter F Buckley
    Medical College of Georgia, Department of Psychiatry and Behavioral Health, 1515 Pope Avenue, Augusta, GA 30192 3800
    Schizophr Res 55:99-104. 2002
    ..Head size was found to be normal in schizophrenia. The relationship of brain size to head size is elaborated...